STOCK TITAN

Zodiac's $0.82/Share Offer for Destination XL (NASDAQ: DXLG)

(Neutral)
(Neutral)
Form Type
SC TO-T/A

Rhea-AI Filing Summary

Zodiac Partners II, LLC and Camac Fund, LP have launched a cash tender offer to purchase all outstanding shares of Destination XL Group, Inc. The Offer proposes to pay $0.82 per share in cash, "upon the terms and subject to the conditions set forth in the Offer to Purchase". The Schedule TO Amendment No. 1 incorporates the Offer to Purchase, Letter of Transmittal and related exhibits, and references an $75 million Revolving Credit Facility term sheet and an Equity Commitment Letter as financing sources. The Offer materials are dated May 12, 2026 with this amendment signed May 27, 2026.

Positive

  • None.

Negative

  • None.

Insights

Schedule TO amendment formalizes a $0.82/share cash tender offer and attached financing exhibits.

The filing states the Purchaser will buy all outstanding shares at $0.82 per share "upon the terms and subject to the conditions set forth in the Offer to Purchase." The filing references an Equity Commitment Letter and a confidential $75 million Revolving Credit Facility term sheet as components of funding.

Key legal dependencies include the Offer conditions and any regulatory or approval provisions set forth in the Offer to Purchase; timing and completion depend on satisfaction of those conditions and on the financing documents referenced in the exhibits.

Transaction is a full‑company cash tender at $0.82 per share, backed by equity and a credit term sheet.

The Schedule TO ties the Offer to an Equity Commitment Letter and a Revolving Credit Facility term sheet (indicative, confidential portions redacted). The filing does not disclose pro forma capitalization or sources allocation beyond naming those exhibits.

Financial close and seller participation will determine actual cash required; subsequent filings may disclose accepted share counts and financing draws as the Offer proceeds.

Offer price $0.82 per share cash tender offer to purchase all outstanding shares
CUSIP 25065K104 Destination XL common stock CUSIP
Indicative credit facility $75 million Revolving Credit Facility term sheet (exhibit; confidential portions requested)
Offer date May 12, 2026 Offer to Purchase dated
Amendment date May 27, 2026 Schedule TO Amendment No. 1 signature date
Tender Offer regulatory
"to purchase all outstanding shares of common stock at $0.82 per Share"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
Letter of Transmittal financial
"the accompanying Letter of Transmittal, copies of which are attached hereto as Exhibits"
A letter of transmittal is a written form investors use when sending physical stock certificates or electronic ownership documents to a company or its agent to surrender shares, tender them in an offer, or claim payment or replacement securities. It acts like a packing slip that lists what is enclosed, gives instructions on how the transfer should be handled, and provides proof of the transaction—important for ensuring investors receive the correct payment or new securities without delay or dispute.
Equity Commitment Letter financial
"Equity Commitment Letter between Zodiac Partners II, LLC and Camac Fund LP"
A written promise from an investor or group to provide a specified amount of capital for a deal, such as an acquisition or a new financing round. It matters to investors because it shows how likely a transaction is to close and how much fresh money will be available, similar to a down-payment commitment when buying a house: the stronger the promise, the less risk that the deal will fall apart or that existing shareholders will face unexpected dilution.
Revolving Credit Facility Term Sheet financial
"Indicative $75 million Revolving Credit Facility Term Sheet (confidential treatment requested)"
Notice of Guaranteed Delivery regulatory
"Exhibit (a)(1)(C) | Notice of Guaranteed Delivery"
A notice of guaranteed delivery is a short, written promise used when investors want to sell shares in a tender offer but cannot deliver the physical or electronic share certificates by the offer deadline. It acts like a post-dated IOU: the seller guarantees they will provide the required documents within a short, specified window while still qualifying for the offer’s price and terms. For investors this preserves their right to participate in a deal while giving extra time to complete paperwork, but it also creates a reliance on timely follow-through to receive payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What price is Zodiac offering for Destination XL (DXLG)?

The Offer proposes $0.82 per share in cash. The Offer to Purchase and Letter of Transmittal, dated May 12, 2026, set the payment and procedural terms for tendering shares.

Who is making the offer for DXLG?

Zodiac Partners II, LLC, an acquisition entity of Camac Fund, LP, is the Purchaser. The Schedule TO amendment identifies those entities and their roles in the tender offer.

How is the tender offer financed for DXLG?

The filing references an Equity Commitment Letter and an indicative $75 million Revolving Credit Facility term sheet among exhibits, indicating a mix of equity and committed credit support for the Offer.

Does the Schedule TO state any conditions for the offer's completion?

Yes. The Offer is to be completed "upon the terms and subject to the conditions set forth in the Offer to Purchase." The specific conditions are detailed in the Offer to Purchase exhibit.

When were the Offer materials filed and amended?

The Offer to Purchase is dated May 12, 2026, and this Amendment No. 1 to the Schedule TO is signed and dated May 27, 2026, as shown in the filing.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

AMENDMENT NO. 1 TO

SCHEDULE TO

 

Tender Offer Statement Under Section 14(d)(1) or 13(e)(1)

of the Securities Exchange Act of 1934

 

Destination XL Group, Inc.

(Name of Subject Company)

 

Zodiac Partners II, LLC

(Name of Filing Person (Offeror))

 

Camac Fund, LP

(Name of Filing Person (Parent of Offeror))

 

Common Stock, par value $0.01 per share

(Title of Class of Securities)

 

25065K104

(CUSIP Number of Class of Securities)

 

Craig Rosmarin

Chief Financial Officer

1601-1 N Main St #3159, SMB#92283, Jacksonville, FL 32206

(917) 692-1844

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on

Behalf of Filing Persons)

 

Copies to:

Donald R. Reynolds

Wyrick Robbins Yates & Ponton LLP

4101 Lake Boone Trail, Suite 300

Raleigh, NC 27607

(919) 781-4000

 

 ☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
   
Check the appropriate boxes below to designate any transactions to which the statement relates:
 
  third-party tender offer subject to Rule 14d-1.
     
  issuer tender offer subject to Rule 13e-4.
     
  going-private transaction subject to Rule 13e-3.
     
  amendment to Schedule 13D under Rule 13d-2.
     
Check the following box if the filing is a final amendment reporting the results of the tender offer.  ☐
 
If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:
 
  Rule 13e-4(i) (Cross-Border Issuer Tender Offer)
     
  Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)

 

 

 

 
 

 

This Amendment No. 1 to Tender Offer Statement on Schedule TO (this “Schedule TO”) is filed by Camac Fund, LP, a Delaware limited partnership (“Camac Fund”), and Zodiac Partners II, LLC, a Delaware limited liability company (the “Purchaser”, “Zodiac Partners II, LLC”) and an acquisition entity of Camac Fund. This Schedule TO relates to the offer by the Purchaser to purchase all outstanding shares of common stock, par value $0.01 per share (the “Shares”), of Destination XL Group, Inc., a Delaware corporation (“DXL”), at $0.82 per Share, to the seller in cash, without interest and less any required withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase, originally dated May 12, 2026 (the “Offer to Purchase”), and in the accompanying Letter of Transmittal, copies of which are attached hereto as Exhibits (a)(1)(A) and (a)(1)(B), respectively, which, together with any amendments or supplements thereto, collectively constitute the “Offer”.

 

Item 1. Summary Term Sheet.

 

The information set forth in the Offer to Purchase under the caption SUMMARY TERM SHEET is incorporated herein by reference.

 

Item 2. Subject Company Information.

 

(a) The name, address, and telephone number of the subject company’s principal executive offices are as follows:

 

Destination XL Group, Inc.

555 Turnpike Street

Canton, MA 02021

 

(b) This Schedule TO relates to the Offer by the Purchaser to purchase all of the issued and outstanding Shares. According to DXL’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 19, 2026 (the “DXL FY2025 Form 10-K”), as of March 9, 2026 there were 54,810,511 Shares issued and outstanding, and based on the Purchaser’s review of the DXL FY2025 Form 10-K, we believe as of January 31, 2026, there were approximately 44,000 stock options to purchase Shares, and 1,259,000 restricted stock units outstanding.

 

(c) The information set forth under the caption THE OFFER - Section 6 (“Price Range of Shares; Dividends”) and Section 11 (“Background of the Offer”) of the Offer to Purchase is incorporated herein by reference.

 

Item 3. Identity and Background of Filing Person.

 

(a)-(c) The filing companies of this Schedule TO are (i) Camac Fund LP, and (ii) the Purchaser, Zodiac Partners II, LLC. The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 9 (“Certain Information Concerning the Purchaser, Zodiac Partners II, LLC, and Camac Fund, LP”) and Schedule I attached thereto.

 

 
 

 

Item 4. Terms of the Transaction.

 

(a)(1)(i)-(viii), (x), (xii), (a)(2) The information set forth in the Offer to Purchase is incorporated herein by reference.

 

Subsections (a)(1)(ix) and (xi) are not applicable.

 

Item 5. Past Contacts, Transactions, Negotiations and Agreements.

 

(a), (b) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

INTRODUCTION

 

THE OFFER - Section 9 (“Certain Information Concerning the Purchaser, Zodiac Partners II, LLC, and Camac Fund, LP”) and Schedule I attached thereto

 

THE OFFER - Section 10 (“Source and Amount of Funds”) and Schedule I attached thereto

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 12 (“Purpose of the Offer and the Proposed Merger; Plans for DXL; Statutory Requirements; Approval of the Proposed Merger”)

 

Item 6. Purposes of the Transaction and Plans or Proposals.

 

(a) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

INTRODUCTION

 

THE OFFER - Section 12 (“Purpose of the Offer and the Proposed Merger; Plans for DXL; Statutory Requirements; Approval of the Proposed Merger”)

 

(c) (1)-(7) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

INTRODUCTION

 

THE OFFER - Section 7 (“Possible Effects of the Offer on the Market for the Shares; Stock Exchange Listing; Registration Under the Exchange Act; Margin Regulations”)

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 13 (“Dividends and Distributions”)

 

Item 7. Source and Amount of Funds or Other Consideration.

 

(a), (b), (d) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 10 (“Source and Amount of Funds”)

 

THE OFFER - Section 17 (“Fees and Expenses”)

 

 
 

 

Item 8. Interest in Securities of the Subject Company.

 

(a), (b) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

THE OFFER - Section 9 (“Certain Information Concerning the Purchaser, Zodiac Partners II, LLC, and Camac Fund, LP”) and Schedule I attached thereto

 

THE OFFER - Section 11 (“Background of the Offer”)

 

Item 9. Persons/Assets, Retained, Employed, Compensated or Used.

 

(a) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 2 (“Acceptance for Payment and Payment for Shares”)

 

THE OFFER - Section 3 (“Procedure for Tendering Shares”)

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 17 (“Fees and Expenses”)

 

Item 10. Financial Statements.

 

(a) Not applicable.

 

(b) Not applicable.

 

Item 11. Additional Information.

 

(a) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 7 (“Possible Effects of the Offer on the Market for the Shares; Stock Exchange Listing; Registration Under the Exchange Act; Margin Regulations”)

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 12 (“Purpose of the Offer and the Proposed Merger; Plans for DXL; Statutory Requirements; Approval of the Proposed Merger”)

 

THE OFFER - Section 14 (“Conditions of the Offer”)

 

THE OFFER - Section 15 (“Certain Legal Matters; Regulatory Approvals; Appraisal Rights”)

 

(c)

The information set forth in the Offer to Purchase and the Letter of Transmittal is incorporated herein by reference.

 

 
 

 

Item 12. Exhibits.

 

Exhibit Description
(a)(1)(A) Amended Offer to Purchase, dated May 27, 2026.*
(a)(1)(B) Form of Letter of Transmittal.
(a)(5)(A) Press Release Issued by Zodiac Partners II, LLC on May 12, 2026.
(d)    Equity Commitment Letter between Zodiac Partners II, LLC and Camac Fund LP, dated May 11, 2026.
(b)    Indicative $75 million Revolving Credit Facility Term Sheet (confidential treatment has been requested for certain portions of this exhibit).*
107   Filing Fee Exhibit.
(a)(1)(C)   Notice of Guaranteed Delivery.*
(e)   Schedule I.*
(a)(1)(F)   W-9 Guidelines.*
(a)(1)(E)   Letter to Clients.*
(h)   Press Release Issued by Zodiac Partners II, LLC on May 21, 2026.*

 

* Asterisk describes exhibits filed herewith. No asterisk means the exhibit has been previously filed.

 

Item 13. Information Required by Schedule 13E-3.

 

Not applicable.

 

 
 

 

SIGNATURE

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: May 27, 2026    
  Zodiac Partners II, LLC
   
  By: /s/ Ziggy Gokea
  Name: Ziggy Gokea
  Title: Managing Member
     
  Camac Fund, LP
   
  By: /s/ Eric Shahinian
  Name: Eric Shahinian
  Title: Manager of GP